Polypharmacy, or the concurrent use of five or more medications, is common in older adults and increases the risk of adverse drug interactions. While deprescribing unnecessary drugs can […]
An American born in 2019 will spend a larger share of their lifetime taking prescription drugs than being married or receiving an education, according to new research by […]
When older adults with cancer take multiple medications — including ordinary drugs like blood pressure pills, supplements, or antacids — it can result in more toxic chemotherapy side […]
People with dementia are likely to have taken more than three medications for other health conditions in the five years directly before their diagnosis, according to new research. […]
Researchers at the University of Liverpool have identified an increasing trend in medicine-related harm leading to hospital admission. The trend is connected to a rising tide of multiple […]
Here’s a scenario so common that it applies to nearly 92 percent of older adults with cancer: An individual comes in for treatment and reports taking several medications […]
Dr Claire Scullin explains how the iSIMPATHY project has been designed to end up with sustainable scheme to manage polypharmacy that has been rigorously evaluated. By 2022 it […]
Drs Claire Scullin and Joanne Brown describes how prescribing pharmacists will carry out in-depth medication reviews for hospital inpatients and make any changes needed to prescriptions as part […]
Polypharmacy, or the concomitant use of multiple medicines, is estimated to cost $18 billion and account for 8.6 million hospital admissions annually in the European Union. The iSIMPATHY […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.
